Spero Therapeutics announced that CEO Esther Rajavelu will participate in a fireside chat at the Guggenheim Healthcare Innovation Conference in Boston on November 10. The company's leadership will also attend the Jefferies Global Healthcare Conference in London from November 18-19, meeting with investors. These events highlight Spero's efforts to advance its immunology pipeline and engage with the investment community. Their lead drug candidate, SP001, targets immune-mediated diseases, underscoring the company's focus on next-generation medicines.
Spero Therapeutics' upcoming investor conference appearances provide context for healthcare sector activity on Pluang. For readers following healthcare stocks, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 150 priced US health-sector stocks, 48 rose and 100 fell. Notable moves included Illumina, Inc. (ILMN) down 18.39% at USD 236.73 with a typical hold time of 84 days, American Well Corp (AMWL) down 15.15% at USD 12.71 with 100% buy order activity and a 62-day hold, and Regeneron Pharmaceuticals Inc (REGN) up 13.27% at USD 927.38 with 80% sell order activity and a 108-day hold time.
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
Centerspace announced a net income of $7.28 per diluted share for Q3 2026, up from $3.19 in the prior year, driven by gains from selling 14 apartment communities. Despite flat same-store revenues, property expenses rose 4.2%, causing a 2.7% decline i...
XAI Floating Rate & Alternative Income Trust announced a monthly dividend of $0.225 per common share, payable on December 1, 2026, unchanged from the previous month. The dividend will be paid to shareholders of record as of November 16, 2026. Distrib...
